MX2018008545A - Composicion antibacteriana y metodo para tratar infecciones por estafilococos con la composicion antibacteriana. - Google Patents
Composicion antibacteriana y metodo para tratar infecciones por estafilococos con la composicion antibacteriana.Info
- Publication number
- MX2018008545A MX2018008545A MX2018008545A MX2018008545A MX2018008545A MX 2018008545 A MX2018008545 A MX 2018008545A MX 2018008545 A MX2018008545 A MX 2018008545A MX 2018008545 A MX2018008545 A MX 2018008545A MX 2018008545 A MX2018008545 A MX 2018008545A
- Authority
- MX
- Mexico
- Prior art keywords
- antibacterial composition
- staphylococcal infections
- antibacterial
- treating staphylococcal
- seq
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 7
- 206010041925 Staphylococcal infections Diseases 0.000 title abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Abstract
Un método para tratar infecciones por estafilococos que incluye administrar a un sujeto una cantidad eficaz de una composición antibacteriana que tiene una amplia actividad bactericida. La composición antibacteriana incluye una primera proteína antibacteriana que consiste en la secuencia aminoacídica como se expone en la SEQ. ID. NO:1 y/o una segunda proteína antibacteriana que consiste en la secuencia aminoacídica como se expone en la SEQ. ID. NO:2.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662277506P | 2016-01-12 | 2016-01-12 | |
| PCT/IB2017/050087 WO2017122111A1 (en) | 2016-01-12 | 2017-01-09 | An antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018008545A true MX2018008545A (es) | 2018-12-19 |
| MX394323B MX394323B (es) | 2025-03-24 |
Family
ID=59310874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018008545A MX394323B (es) | 2016-01-12 | 2017-01-09 | Uso de una composición antibacteriana para tratar infecciones por estafilococos. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11229677B2 (es) |
| EP (1) | EP3402506A4 (es) |
| JP (1) | JP7085483B2 (es) |
| KR (1) | KR102669340B1 (es) |
| CN (1) | CN109414478B (es) |
| AU (1) | AU2017208114B2 (es) |
| BR (1) | BR112018014175A2 (es) |
| CA (1) | CA3010564C (es) |
| MX (1) | MX394323B (es) |
| MY (1) | MY199203A (es) |
| RU (2) | RU2707738C1 (es) |
| SG (1) | SG11201811479RA (es) |
| UA (2) | UA128879C2 (es) |
| WO (1) | WO2017122111A1 (es) |
| ZA (1) | ZA201804013B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110734474B (zh) * | 2019-11-29 | 2021-10-19 | 中山大学 | 一种抗菌肽的筛选方法及其应用 |
| CN111235119B (zh) * | 2020-03-05 | 2021-11-23 | 苏州十一方生物科技有限公司 | 一种融合抗菌蛋白的制备及应用 |
| CN112402591B (zh) * | 2020-11-23 | 2022-12-16 | 中国农业科学院饲料研究所 | 防御素dlp4在治疗仔猪渗出性皮炎中的应用 |
| KR102426421B1 (ko) * | 2021-01-06 | 2022-07-29 | 주식회사 리신바이오 | 신규 재조합 엔도라이신 및 이의 용도 |
| KR102739428B1 (ko) * | 2022-07-26 | 2024-12-11 | 주식회사 인트론바이오테크놀로지 | 황색포도알균을 포함한 포도알균에 대하여 강력한 용균 활성을 갖는 항균단백질 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1516628E (pt) | 1995-07-27 | 2013-09-24 | Genentech Inc | Formulação de proteína liofilizada isotónica estável |
| IE20060488A1 (en) * | 2006-06-29 | 2008-01-09 | Teagasc Agric Food Dev Authori | Recombinant staphylococcal phage lysin as an antibacterial agent |
| KR100759988B1 (ko) * | 2006-08-04 | 2007-09-19 | 주식회사 인트론바이오테크놀로지 | 황색포도상구균에 특이적인 항균 단백질 |
| KR100910961B1 (ko) * | 2007-09-13 | 2009-08-05 | 주식회사 인트론바이오테크놀로지 | 황색포도상구균의 균막 처치에 효과적인 박테리오파지 또는그것 유래의 용균단백질 |
| KR101016918B1 (ko) | 2009-01-08 | 2011-02-25 | 주식회사 인트론바이오테크놀로지 | 박테리아 특이적 넓은 항균 활성을 갖는 신규한 리신 단백질 |
| US8043613B2 (en) * | 2009-02-12 | 2011-10-25 | Intron Biotechnology, Inc. | Podoviriedae bacteriophage having killing activity specific to Staphylococcus aureus |
| US9603909B2 (en) * | 2012-05-29 | 2017-03-28 | Intron Biotechnology, Inc. | Composition capable of improving stability of bacteriophage lysin proteins |
| RU2734308C2 (ru) * | 2016-01-12 | 2020-10-15 | Интрон Байотекнолоджи, Инк. | Лиофилизированные композиции антибактериального белка |
-
2017
- 2017-01-09 CA CA3010564A patent/CA3010564C/en active Active
- 2017-01-09 RU RU2018124798A patent/RU2707738C1/ru active
- 2017-01-09 RU RU2019136978A patent/RU2729934C2/ru active
- 2017-01-09 BR BR112018014175-5A patent/BR112018014175A2/en not_active Application Discontinuation
- 2017-01-09 WO PCT/IB2017/050087 patent/WO2017122111A1/en not_active Ceased
- 2017-01-09 MX MX2018008545A patent/MX394323B/es unknown
- 2017-01-09 UA UAA202201525A patent/UA128879C2/uk unknown
- 2017-01-09 US US16/300,566 patent/US11229677B2/en active Active
- 2017-01-09 SG SG11201811479RA patent/SG11201811479RA/en unknown
- 2017-01-09 CN CN201780006444.8A patent/CN109414478B/zh active Active
- 2017-01-09 EP EP17738258.7A patent/EP3402506A4/en active Pending
- 2017-01-09 MY MYPI2018002704A patent/MY199203A/en unknown
- 2017-01-09 UA UAA201813040A patent/UA126022C2/uk unknown
- 2017-01-09 KR KR1020187021859A patent/KR102669340B1/ko active Active
- 2017-01-09 AU AU2017208114A patent/AU2017208114B2/en active Active
- 2017-01-09 JP JP2018536456A patent/JP7085483B2/ja active Active
-
2018
- 2018-06-15 ZA ZA2018/04013A patent/ZA201804013B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3010564A1 (en) | 2017-07-20 |
| BR112018014175A2 (en) | 2018-12-26 |
| UA126022C2 (uk) | 2022-08-03 |
| US11229677B2 (en) | 2022-01-25 |
| US20190282657A1 (en) | 2019-09-19 |
| AU2017208114A1 (en) | 2018-07-26 |
| RU2729934C2 (ru) | 2020-08-13 |
| RU2707738C1 (ru) | 2019-11-29 |
| MX394323B (es) | 2025-03-24 |
| KR20180114010A (ko) | 2018-10-17 |
| ZA201804013B (en) | 2019-07-31 |
| CN109414478B (zh) | 2022-08-23 |
| CA3010564C (en) | 2024-01-30 |
| CN109414478A (zh) | 2019-03-01 |
| RU2019136978A (ru) | 2019-12-19 |
| AU2017208114B2 (en) | 2023-04-13 |
| EP3402506A1 (en) | 2018-11-21 |
| KR102669340B1 (ko) | 2024-05-28 |
| SG11201811479RA (en) | 2019-01-30 |
| JP2019503379A (ja) | 2019-02-07 |
| RU2019136978A3 (es) | 2020-04-02 |
| JP7085483B2 (ja) | 2022-06-16 |
| UA128879C2 (uk) | 2024-11-13 |
| EP3402506A4 (en) | 2019-09-04 |
| MY199203A (en) | 2023-10-19 |
| WO2017122111A1 (en) | 2017-07-20 |
| NZ749842A (en) | 2024-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2017009843A3 (en) | Compositions, articles of manufacture and methods for treating cancer | |
| MY199203A (en) | An antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition | |
| EP4349360A3 (en) | Peptide exhibiting wrinkle-improving activity and uses thereof | |
| WO2018115140A3 (en) | Virulence attenuated bacteria based protein delivery | |
| WO2012003474A3 (en) | Compositions and methods related to protein a (spa) variants | |
| MX2018001075A (es) | Agentes terapeuticos y profilacticos antibacterianos. | |
| EA201500802A1 (ru) | Способы профилактики и/или лечения кардиомиопатии и устранения симптомов кардиомиопатии, фармацевтическая композиция, векторы | |
| MY200975A (en) | "Compositions Comprising Amino acids for use in the Treatment of Mitochondrial Dysfunction-Related Diseases" | |
| MX369056B (es) | Prevención, interrupción y tratamiento de biopelículas con lisina de bacteriófago. | |
| MX2017012545A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| WO2017176807A9 (en) | Compositions for inhibiting formation of and/or disrupting bacterial biofilms and methods of use therefor | |
| WO2017075188A3 (en) | Methods of using anti-alpha toxin antibody | |
| MX2019006768A (es) | Peptidos antimicrobianos. | |
| EA201991501A1 (ru) | Противомикробная композиция, содержащая олигодинамический металл | |
| MX2017012535A (es) | Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| BR112014028130A2 (pt) | Sal de cloridrato de um peptídeo, composição farmacêutica, uso de um sal de cloridrato, uso de uma composição farmacêutica, e, método para evitar ou tratar alergia a gatos | |
| PH12018500358A1 (en) | Compounds for use in an antibacterial applications | |
| JP2013539776A5 (es) | ||
| WO2015075062A3 (en) | Method of treating hair | |
| MX2017014080A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| MX2020001084A (es) | Composiciones que comprenden aminoacidos para su uso en el tratamiento de enfermedades relacionadas con la disfuncion mitocondrial. | |
| MX2017016227A (es) | Peptidos anti-infecciosos de amplio espectro. | |
| EA201590601A1 (ru) | Применение pedf-производных полипептидов для лечения остеоартрита | |
| MX373912B (es) | Terapias antibioticas peptidicas derivadas del bufalo de agua | |
| MY187334A (en) | Xylanase |